Phathom Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Phathom Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Phathom Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $833K, a 50.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $833K -$849K -50.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.05M -$836K -44.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.26M -$824K -39.5% Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 $1.48M -$812K -35.5% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.68M -$800K -32.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.89M -$671K -26.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.09M +$293K +16.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $2.29M +$373K +19.5% Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 $2.48M +$451K +22.2% Sep 30, 2022 10-Q/A 2022-11-09
Q2 2022 $2.56M +$410K +19.1% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $1.8M -$466K -20.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.91M -$459K -19.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2.03M -$454K -18.3% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $2.15M -$467K -17.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $2.26M +$1.32M +141% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.37M +$1.44M +154% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $2.49M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $2.61M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $939K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $933K Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.